EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Shigeru Sakamoto
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takeuchi, K.
Right arrow Articles by Matsubara, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takeuchi, K.
Right arrow Articles by Matsubara, J.
Related Collections
Right arrow Cardiac - pharmacology
Right arrow Cardiac - other
Right arrow Coronary disease

Eur J Cardiothorac Surg 2004;26:956-959
© 2004 Elsevier Science NL


Reactivity of the human internal thoracic artery to vasodilators in coronary artery bypass grafting

Katsunori Takeuchi*, Shigeru Sakamoto, Yasuhiro Nagayoshi, Hisateru Nishizawa, Junichi Matsubara

Department of Cardiovascular Surgery, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Kahokugun, Ishikawa 920-0265, Japan

Received 8 April 2004; received in revised form 12 July 2004; accepted 23 July 2004.

* Corresponding author. Tel.: +81 76 286 2211; fax: +81 76 286 2322. (E-mail: katsu-i{at}kanazawa-med.ac.jp).

Objective: The internal thoracic artery (ITA) is a useful conduit for coronary artery bypass grafting (CABG) and the patency rate is indispensable. Recently we have developed a method for increasing ITA blood flow during surgery by directly injecting phosphodiesterase III inhibitor (PDE III-I) into the left ITA (LITA) to prevent its contracture. In this study, we compared the reactivity of LITA blood flows before and after injection of four drugs: saline, papaverine hydrochloride, isosorbide dinitrate (ISDN), and PDE III-I. Method: 80 patients who were undergoing the first primary CABG, were randomly separated into four groups. Each group consisted of 20 patients. LITA graft free flow (GFF) and systemic mean blood pressure (MBP) were measured before and 1min after direct intra LITA drug administration and blood vessel resistance (R) was calculated. Result: The saline group showed no significant changes in GFF, R value, and MBP. Significant increase in GFF was observed in the PDE III-I and ISDN groups. Except the saline group, each group exhibited a significant decrease in both the R value and MBP. A comparison of the change rate of MBP showed no significant differences among the four groups. The PDE III-I significantly increased the change rate of GFF and decreased the change rate of R value, when compared to the saline and papaverine hydrochloride groups. The PDE III-I showed a tendency to increase the change rate of GFF and to decrease the change rate of the R value compared to the ISDN group. Conclusion: The results of this study suggested that the PDE III-I is the most effective for increasing the blood flow of a LITA graft for CABG during surgery.




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
S. Novella, A. C. Martinez, R. M. Pagan, M. Hernandez, A. Garcia-Sacristan, A. Gonzalez-Pinto, J. M. Gonzalez-Santos, and S. Benedito
Plasma levels and vascular effects of vasopressin in patients undergoing coronary artery bypass grafting
Eur. J. Cardiothorac. Surg., July 1, 2007; 32(1): 69 - 76.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.